Ws Management Lllp Intellia Therapeutics, Inc. Transaction History

Ws Management Lllp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$60.88 - $161.91 $811,104 - $2.16 Million	-13,323 Reduced 33.33%	26,646 $4.31 Million
Q1 2021 May 13, 2021	SELL	$46.59 - $83.68 $95,462 - $171,460	-2,049 Reduced 4.88%	39,969 $3.21 Million
Q2 2020 Aug 13, 2020	SELL	$11.14 - $22.87 $80,341 - $164,938	-7,212 Reduced 14.65%	42,018 $883,000
Q1 2020 May 13, 2020	SELL	$9.44 - $15.58 $23,316 - $38,482	-2,470 Reduced 4.78%	49,230 $602,000
Q3 2019 Nov 13, 2019	SELL	$13.07 - $18.51 $74,394 - $105,358	-5,692 Reduced 9.92%	51,700 $690,000
Q2 2019 Aug 13, 2019	SELL	$13.88 - $18.41 $94,050 - $124,746	-6,776 Reduced 10.56%	57,392 $940,000
Q1 2019 May 13, 2019	SELL	$12.79 - $17.62 $110,377 - $152,060	-8,630 Reduced 11.85%	64,168 $1.1 Million
Q4 2018 Feb 12, 2019	SELL	$11.39 - $27.13 $537,630 - $1.28 Million	-47,202 Reduced 39.34%	72,798 $994,000
Q2 2018 Aug 13, 2018	BUY	$20.02 - $30.79 $2.4 Million - $3.69 Million	120,000 New	120,000 $3.28 Million

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $707M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.